{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T21:21:03Z","timestamp":1790371263447,"version":"4.1.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,2,21]],"date-time":"2020-02-21T00:00:00Z","timestamp":1582243200000},"content-version":"am","delay-in-days":357,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"FIGHT-MG","award":["HEALTH-2009-242-210"],"award-info":[{"award-number":["HEALTH-2009-242-210"]}]},{"DOI":"10.13039\/100013465","name":"Association Fran\u00e7aise contre les Myopathies","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013465","id-type":"DOI","asserted-by":"publisher"}]},{"name":"CONACYT"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.jaut.2018.11.005","type":"journal-article","created":{"date-parts":[[2018,12,18]],"date-time":"2018-12-18T09:21:07Z","timestamp":1545124867000},"page":"59-73","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":57,"special_numbering":"C","title":["Il-23\/Th17 cell pathway: A promising target to alleviate thymic inflammation maintenance in myasthenia gravis"],"prefix":"10.1016","volume":"98","author":[{"given":"Jos\u00e9 A.","family":"Villegas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra C.","family":"Bayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katia","family":"Ider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacky","family":"Bismuth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9rique","family":"Truffault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00e9gine","family":"Roussin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Santelmo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7522-5974","authenticated-orcid":false,"given":"Rozen","family":"Le Panse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9199-4175","authenticated-orcid":false,"given":"Sonia","family":"Berrih-Aknin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Dragin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2018.11.005_bib1","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jaut.2013.12.011","article-title":"Myasthenia gravis: a comprehensive review of immune dysregulation and etiological mechanisms","volume":"52","author":"Berrih-Aknin","year":"2014","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2018.11.005_bib2","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.89665","article-title":"Preconditioned mesenchymal stem cells treat myasthenia gravis in a humanized preclinical model","volume":"2","author":"Sudres","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.jaut.2018.11.005_bib3","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1056\/NEJMoa1602489","article-title":"Randomized trial of thymectomy in myasthenia gravis","volume":"375","author":"Wolfe","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jaut.2018.11.005_bib4","doi-asserted-by":"crossref","first-page":"7868","DOI":"10.4049\/jimmunol.177.11.7868","article-title":"Microarrays reveal distinct gene signatures in the thymus of seropositive and seronegative myasthenia gravis patients and the role of CC chemokine ligand 21 in thymic hyperplasia","volume":"177","author":"Le Panse","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2018.11.005_bib5","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3109\/08916930903563491","article-title":"Thymic remodeling associated with hyperplasia in myasthenia gravis","volume":"43","author":"Le Panse","year":"2010","journal-title":"Autoimmunity"},{"key":"10.1016\/j.jaut.2018.11.005_bib6","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1182\/blood-2003-11-3900","article-title":"Functional defect of regulatory CD4(+)CD25+ T cells in the thymus of patients with autoimmune myasthenia gravis","volume":"105","author":"Balandina","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2018.11.005_bib7","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.clim.2012.09.012","article-title":"Impaired regulatory function in circulating CD4(+)CD25(high)CD127(low\/-) T cells in patients with myasthenia gravis","volume":"145","author":"Thiruppathi","year":"2012","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.jaut.2018.11.005_bib8","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jaut.2013.12.015","article-title":"Both Treg cells and Tconv cells are defective in the Myasthenia gravis thymus: roles of IL-17 and TNF-alpha","volume":"52","author":"Gradolatto","year":"2014","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2018.11.005_bib9","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.cyto.2015.06.011","article-title":"Elevated plasma interleukin-17A in a subgroup of Myasthenia Gravis patients","volume":"78","author":"Xie","year":"2016","journal-title":"Cytokine"},{"key":"10.1016\/j.jaut.2018.11.005_bib10","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1182\/blood-2005-06-2383","article-title":"The chemokine CXCL13 is a key molecule in autoimmune myasthenia gravis","volume":"108","author":"Meraouna","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2018.11.005_bib11","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1002\/eji.201445064","article-title":"IL-17-producing CD4(+) T cells contribute to the loss of B-cell tolerance in experimental autoimmune myasthenia gravis","volume":"45","author":"Schaffert","year":"2015","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jaut.2018.11.005_bib12","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.jneuroim.2006.07.004","article-title":"CD4+ T and B cells cooperate in the immunoregulation of experimental autoimmune myasthenia gravis","volume":"179","author":"Milani","year":"2006","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jaut.2018.11.005_bib13","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ajpath.2012.03.044","article-title":"Th17 cells: biology, pathogenesis of autoimmune and inflammatory diseases, and therapeutic strategies","volume":"181","author":"Maddur","year":"2012","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jaut.2018.11.005_bib14","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.immuni.2011.10.015","article-title":"Th17 cells induce ectopic lymphoid follicles in central nervous system tissue inflammation","volume":"35","author":"Peters","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.jaut.2018.11.005_bib15","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.molimm.2012.11.013","article-title":"Podoplanin is an inflammatory protein upregulated in Th17 cells in SKG arthritic joints","volume":"54","author":"Miyamoto","year":"2013","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.jaut.2018.11.005_bib16","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1172\/JCI74685","article-title":"Podoplanin negatively regulates CD4+ effector T cell responses","volume":"125","author":"Peters","year":"2015","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.jaut.2018.11.005_bib17","doi-asserted-by":"crossref","first-page":"e1420","DOI":"10.1038\/cddis.2014.377","article-title":"Human thymus medullary epithelial cells promote regulatory T cell generation by stimulating interleukin-2 production via ICOS ligand","volume":"5","author":"Nazzal","year":"2014","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.jaut.2018.11.005_bib18","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.3389\/fimmu.2018.01663","article-title":"Cultured human thymic-derived cells display medullary thymic epithelial cell phenotype and functionality","volume":"9","author":"Villegas","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2018.11.005_bib19","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1172\/JCI81894","article-title":"Estrogen-mediated downregulation of AIRE influences sexual dimorphism in autoimmune diseases","volume":"126","author":"Dragin","year":"2016","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.jaut.2018.11.005_bib20","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jaut.2013.12.018","article-title":"Thymoma-associated myasthenia gravis: on the search for a pathogen signature","volume":"52","author":"Cufi","year":"2014","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2018.11.005_bib21","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.4049\/jimmunol.176.3.1908","article-title":"In vitro and in situ expression of IL-23 by keratinocytes in healthy skin and psoriasis lesions: enhanced expression in psoriatic skin","volume":"176","author":"Piskin","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2018.11.005_bib22","first-page":"14292","article-title":"Proinflammatory T helper type 17 cells are effective B-cell helpers","volume":"vol. 107","author":"Mitsdoerffer","year":"2010"},{"key":"10.1016\/j.jaut.2018.11.005_bib23","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1016\/j.cell.2015.11.009","article-title":"Single-cell genomics unveils critical regulators of Th17 cell pathogenicity","volume":"163","author":"Gaublomme","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.jaut.2018.11.005_bib24","doi-asserted-by":"crossref","first-page":"7768","DOI":"10.4049\/jimmunol.176.12.7768","article-title":"IL-23 is increased in dendritic cells in multiple sclerosis and down-regulation of IL-23 by antisense oligos increases dendritic cell IL-10 production","volume":"176","author":"Vaknin-Dembinsky","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2018.11.005_bib25","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/ana.23791","article-title":"Implication of double-stranded RNA signaling in the etiology of autoimmune myasthenia gravis","volume":"73","author":"Cufi","year":"2013","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jaut.2018.11.005_bib26","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.cellimm.2013.06.011","article-title":"Helper T cells down-regulate CD4 expression upon chronic stimulation giving rise to double-negative T cells","volume":"284","author":"Grishkan","year":"2013","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.jaut.2018.11.005_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2017.12.007","article-title":"A cellular and molecular view of T helper 17 cell plasticity in autoimmunity","volume":"87","author":"Stadhouders","year":"2018","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2018.11.005_bib28","doi-asserted-by":"crossref","first-page":"283","DOI":"10.3389\/fimmu.2012.00283","article-title":"Podoplanin: emerging functions in development, the immune system, and cancer","volume":"3","author":"Astarita","year":"2012","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2018.11.005_bib29","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0896-8411(89)90267-9","article-title":"High recombinant interleukin-2 sensitivity of peripheral blood lymphocytes from patients with myasthenia gravis: correlations with clinical parameters","volume":"2","author":"Cohen-Kaminsky","year":"1989","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2018.11.005_bib30","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1749-6632.1993.tb22873.x","article-title":"High IL-6 gene expression and production by cultured human thymic epithelial cells from patients with myasthenia gravis","volume":"681","author":"Cohen-Kaminsky","year":"1993","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jaut.2018.11.005_bib31","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/mus.22103","article-title":"The thymus in myasthenia gravis: site of \u201cinnate autoimmunity\u201d?","volume":"44","author":"Cavalcante","year":"2011","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jaut.2018.11.005_bib32","doi-asserted-by":"crossref","first-page":"7021","DOI":"10.4049\/jimmunol.175.10.7021","article-title":"Constitutive activation of p38 and ERK1\/2 MAPKs in epithelial cells of myasthenic thymus leads to IL-6 and RANTES overexpression: effects on survival and migration of peripheral T and B cells","volume":"175","author":"Colombara","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2018.11.005_bib33","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/j.1749-6632.1993.tb22874.x","article-title":"In situ production of interleukins in hyperplastic thymus from myasthenia gravis patients","volume":"681","author":"Emilie","year":"1993","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jaut.2018.11.005_bib34","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1196\/annals.1254.031","article-title":"Expression of transforming growth factor-beta1 in thymus of myasthenia gravis patients: correlation with pathological abnormalities","volume":"998","author":"Bernasconi","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jaut.2018.11.005_bib35","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/ni.2416","article-title":"Induction and molecular signature of pathogenic TH17 cells","volume":"13","author":"Lee","year":"2012","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jaut.2018.11.005_bib36","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1038\/nature07036","article-title":"Induction and effector functions of T(H)17 cells","volume":"453","author":"Bettelli","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.jaut.2018.11.005_bib37","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1007\/BF00918185","article-title":"In vitro interleukin-1 (IL-1) production in thymic hyperplasia and thymoma from patients with myasthenia gravis","volume":"11","author":"Aime","year":"1991","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.jaut.2018.11.005_bib38","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/nm.3895","article-title":"IL-12 and IL-23 cytokines: from discovery to targeted therapies for immune-mediated inflammatory diseases","volume":"21","author":"Teng","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.jaut.2018.11.005_bib39","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1002\/eji.201242598","article-title":"IL-23: one cytokine in control of autoimmunity","volume":"42","author":"Croxford","year":"2012","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jaut.2018.11.005_bib40","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1084\/jem.20041257","article-title":"IL-23 drives a pathogenic T cell population that induces autoimmune inflammation","volume":"201","author":"Langrish","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jaut.2018.11.005_bib41","doi-asserted-by":"crossref","first-page":"7072","DOI":"10.4049\/jimmunol.178.11.7072","article-title":"C57BL\/6 mice genetically deficient in IL-12\/IL-23 and IFN-gamma are susceptible to experimental autoimmune myasthenia gravis, suggesting a pathogenic role of non-Th1 cells","volume":"178","author":"Wang","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2018.11.005_bib42","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/nature01355","article-title":"Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain","volume":"421","author":"Cua","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.jaut.2018.11.005_bib43","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.smim.2013.10.009","article-title":"The plasticity of human Treg and Th17 cells and its role in autoimmunity","volume":"25","author":"Kleinewietfeld","year":"2013","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.jaut.2018.11.005_bib44","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1172\/JCI78085","article-title":"Pouring fuel on the fire: Th17 cells, the environment, and autoimmunity","volume":"125","author":"Burkett","year":"2015","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.jaut.2018.11.005_bib45","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/6587296","article-title":"The immunoregulation of Th17 in host against intracellular bacterial infection","volume":"2018","author":"Li","year":"2018","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.jaut.2018.11.005_bib46","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jaut.2013.12.016","article-title":"Central role of interferon-beta in thymic events leading to myasthenia gravis","volume":"52","author":"Cufi","year":"2014","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2018.11.005_bib47","doi-asserted-by":"crossref","first-page":"5941","DOI":"10.4049\/jimmunol.174.10.5941","article-title":"Effects of cytokines on acetylcholine receptor expression: implications for myasthenia gravis","volume":"174","author":"Poea-Guyon","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2018.11.005_bib48","doi-asserted-by":"crossref","first-page":"7970","DOI":"10.1038\/s41598-017-08631-5","article-title":"Balance between estrogens and proinflammatory cytokines regulates chemokine production involved in thymic germinal center formation","volume":"7","author":"Dragin","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jaut.2018.11.005_bib49","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.jaci.2015.05.046","article-title":"Estrogen and progesterone decrease let-7f microRNA expression and increase IL-23\/IL-23 receptor signaling and IL-17A production in patients with severe asthma","volume":"136","author":"Newcomb","year":"2015","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jaut.2018.11.005_bib50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2014.05.001","article-title":"Myasthenia Gravis: paradox versus paradigm in autoimmunity","volume":"52","author":"Berrih-Aknin","year":"2014","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2018.11.005_bib51","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/ni1552","article-title":"Interleukin 17-producing T helper cells and interleukin 17 orchestrate autoreactive germinal center development in autoimmune BXD2 mice","volume":"9","author":"Hsu","year":"2008","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jaut.2018.11.005_bib52","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1182\/blood-2008-01-133967","article-title":"Human CD25highFoxp3pos regulatory T cells differentiate into IL-17-producing cells","volume":"112","author":"Koenen","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2018.11.005_bib53","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1084\/jem.183.6.2593","article-title":"T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines","volume":"183","author":"Fossiez","year":"1996","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jaut.2018.11.005_bib54","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/nri3707","article-title":"The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing","volume":"14","author":"Gaffen","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jaut.2018.11.005_bib55","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/cpt.893","article-title":"Anti-IL-23 and anti-IL-17 biologic agents for the treatment of immune-mediated inflammatory conditions","volume":"103","author":"Frieder","year":"2018","journal-title":"Clin. Pharmacol. Therapeut."}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841118306073?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841118306073?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T08:22:08Z","timestamp":1760257328000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841118306073"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":55,"alternative-id":["S0896841118306073"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2018.11.005","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Il-23\/Th17 cell pathway: A promising target to alleviate thymic inflammation maintenance in myasthenia gravis","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2018.11.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}